Found: 292
Select item for more details and to access through your institution.
Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correction: Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1371353
- By:
- Publication type:
- Article
Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2004, v. 19, n. 6, p. 648, doi. 10.1111/j.1440-1746.2004.03348.x
- By:
- Publication type:
- Article
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
- Published in:
- Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 3, p. 345, doi. 10.1046/j.1440-1746.2002.02600.x
- By:
- Publication type:
- Article
Polymorphisms of the prion protein gene (PRNP) in a Korean population.
- Published in:
- Journal of Human Genetics, 2004, v. 49, n. 6, p. 319, doi. 10.1007/s10038-004-0150-7
- By:
- Publication type:
- Article
The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e80
- By:
- Publication type:
- Article
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e73
- By:
- Publication type:
- Article
A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor (KGOG 3056/NIRVANA-R).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 65, doi. 10.3802/jgo.2024.35.S2.PI-SO2
- By:
- Publication type:
- Article
Comparison of surgical outcomes in single-port laparoscopy with sentinel lymph node biopsy in enhanced recovery after surgery (ERAS) protocol versus conventional laparoscopy surgery for endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 48, doi. 10.3802/jgo.2024.35.S2.P55
- By:
- Publication type:
- Article
Breakthrough of PARP inhibitors resistance treating with the local therapy in recurrent epithelial ovarian cancer patients with oligo-progression.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 42, doi. 10.3802/jgo.2024.35.S2.P42
- By:
- Publication type:
- Article
Weekly paclitaxel with pazopanib for heavily treated ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 36, doi. 10.3802/jgo.2024.35.S2.P30
- By:
- Publication type:
- Article
Impact of clinical trial participation on the survival of patients with newly diagnosed advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 25, doi. 10.3802/jgo.2024.35.S2.P9
- By:
- Publication type:
- Article
PD-L1 as the key to survival for the advanced ovarian cancer previously treated with IDS-HIPEC.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 30, doi. 10.3802/jgo.2024.35.S2.P19
- By:
- Publication type:
- Article
Results from the gynecological cohort in a phase 1/2 study (KEYNOTE-B59): endometrial and cervical cancer patients responded to novel immunocytokine GI-101.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 26, doi. 10.3802/jgo.2024.35.S2.P11
- By:
- Publication type:
- Article
Promising immunotherapeutic strategies based on different immune characteristics of tumor-infiltrating lymphocytes according to molecular classification in endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 27, doi. 10.3802/jgo.2024.35.S2.P12
- By:
- Publication type:
- Article
A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 24, doi. 10.3802/jgo.2024.35.S2.P7
- By:
- Publication type:
- Article
Detection of minimal residual disease using circulating tumor DNA in patients treated with long-term PARP inhibitors maintenance for epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 22, doi. 10.3802/jgo.2024.35.S2.P4
- By:
- Publication type:
- Article
Clinical significance of terminally exhausted CD8 T cells in malignant ascites in patients with epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 24, doi. 10.3802/jgo.2024.35.S2.P8
- By:
- Publication type:
- Article
Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 23, doi. 10.3802/jgo.2024.35.S2.P5
- By:
- Publication type:
- Article
A randomized phase II study of secondary cytoreductive surgery (CRS) in patients with relapsed ovarian cancer who have progressed on PARP inhibitor maintenance: Korean Gynecologic Oncology Group (KGOG 3067)/SOCCER-P trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 21, doi. 10.3802/jgo.2024.35.S2.P3
- By:
- Publication type:
- Article
DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
- By:
- Publication type:
- Article
Surgical outcomes of interval debulking surgery after neoadjuvant chemoimmunotherapy for advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 10, doi. 10.3802/jgo.2024.35.S2.FP-OII1
- By:
- Publication type:
- Article
Distinct immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 8, doi. 10.3802/jgo.2024.35.S2.FP-OI1
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e66
- By:
- Publication type:
- Article
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 1, p. 1, doi. 10.3802/jgo.2024.35.e43
- By:
- Publication type:
- Article
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 6, p. 1, doi. 10.3802/jgo.2023.34.e70
- By:
- Publication type:
- Article
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e45
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e51
- By:
- Publication type:
- Article
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e17
- By:
- Publication type:
- Article
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e45
- By:
- Publication type:
- Article
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 3, p. 1, doi. 10.3802/jgo.2022.33.e44
- By:
- Publication type:
- Article
Prognostic value of complete metabolic response on <sup>18</sup>F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 3, p. 1, doi. 10.3802/jgo.2022.33.e28
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2021.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 2, p. 1, doi. 10.3802/jgo.2022.33.e43
- By:
- Publication type:
- Article
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 2, p. 1, doi. 10.3802/jgo.2022.33.e12
- By:
- Publication type:
- Article
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).
- Published in:
- Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e31
- By:
- Publication type:
- Article
Time for enhancing government-led primary prevention of cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2021, v. 32, n. 1, p. 1, doi. 10.3802/jgo.2021.32.e12
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2019.
- Published in:
- Journal of Gynecologic Oncology, 2020, v. 31, n. 3, p. 1, doi. 10.3802/jgo.2020.31.e48
- By:
- Publication type:
- Article
Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2020, v. 31, n. 2, p. 1, doi. 10.3802/jgo.2020.31.e23
- By:
- Publication type:
- Article
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e112
- By:
- Publication type:
- Article
Involved-field radiation therapy for selected cases of recurrent ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 5, p. 1, doi. 10.3802/jgo.2019.30.e67
- By:
- Publication type:
- Article
How to use immune checkpoint inhibitor in ovarian cancer?
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 5, p. 1, doi. 10.3802/jgo.2019.30.e105
- By:
- Publication type:
- Article
Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 1, p. 1, doi. 10.3802/jgo.2019.30.e3
- By:
- Publication type:
- Article
Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
- Published in:
- Journal of Gynecologic Oncology, 2018, v. 29, n. 4, p. 1, doi. 10.3802/jgo.2018.29.e63
- By:
- Publication type:
- Article
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 6, p. 1, doi. 10.3802/jgo.2017.28.e73
- By:
- Publication type:
- Article
Sentinel lymph node mapping with indocyanine green in vaginal cancer.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 4, p. 1, doi. 10.3802/jgo.2017.28.e29
- By:
- Publication type:
- Article
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 3, p. 1, doi. 10.3802/jgo.2017.28.e22
- By:
- Publication type:
- Article
Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 1, p. 1, doi. 10.3802/jgo.2017.28.e6
- By:
- Publication type:
- Article